Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

